The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Prostaglandin E2 primes naive T cells for the production of anti‐inflammatory cytokines
Abstract
In addition to their capacity to induce pain, vasodilatation and fever, prostaglandins E (PGE) exert anti‐inflammatory activities by inhibiting the release of pro‐inflammatory cytokines by macrophages and T cells, and by increasing interleukin (IL)‐10 production by macrophages. We here report that PGE 2, the major arachidonic acid metabolite released by antigen‐presenting cells (APC), primes naive human T cells for enhanced production of anti‐inflammatory cytokines and inhibition of pro‐inflammatory cytokines. Unfractionated as well as CD45RO−CD31+ sort‐purified neonatal CD4 T cells acquire the capacity to produce a large spectrum of cytokines after priming with anti‐CD3 and anti‐CD28 monoclonal antibodies (mAb), in the absence of both APC and exogenous cytokines. PGE 2 primes naive T cells in a dose‐dependent fashion for production of high levels of IL‐4, IL‐10 and IL‐13, and very low levels of IL‐2, interferon (IFN)‐γ, tumor necrosis factor (TNF)‐α, and TNF‐β. PGE 2 does not significantly increase IL‐4 production in priming cultures, whereas it suppresses IL‐2 and IFN‐γ. Addition of a neutralizing mAb to IL‐4 receptor in primary cultures, supplemented or not with PGE 2, prevents the development of IL‐4‐producing cells but does not abolish the effects of PGE 2 on IL‐10 and IL‐13 as well as T helper (Th)1‐associated cytokines. Addition of exogenous IL‐2 in primary cultures does not alter the effects of PGE 2 on naive T cell maturation. Thus PGE 2 does not act by increasing IL‐4 production in priming cultures, and its effects are partly IL‐4 independent and largely IL‐2 independent. Together with the recent demonstration that PGE 2 suppresses IL‐12 production, our results strongly suggest that this endogenously produced molecule may play a significant role in Th subset development and that its stable analogs may be considered for the treatment of Th1‐mediated inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells
Rincón, M., Anguita, J., Nakamura, T., Fikrig, E., & Flavell, R. A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.3.461 · Cited by 810
Cited by
Navigating metabolic pathways to enhance antitumour immunity and immunotherapy
Li, X., Wenes, M., Romero, P., Huang, S. C.-C., Fendt, S.-M., & Ho, P.-C. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0203-7 · Cited by 733
Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology
Harizi, H., Corcuff, J.-B., & Gualde, N. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.08.005 · Cited by 636
Kaliński, P., Vieira, P. L., Schuitemaker, J. H. N., de Jong, E. C., & Kapsenberg, M. L. (2001) · Blood · doi:10.1182/blood.v97.11.3466 · Cited by 362
Kanto, T., Hayashi, N., Takehara, T., Tatsumi, T., Kuzushita, N., Ito, A., Sasaki, Y., Kasahara, A., & Hori, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5584 · Cited by 356
Role of Antibiotics and Fungal Microbiota in Driving Pulmonary Allergic Responses
Noverr, M. C., Noggle, R. M., Toews, G. B., & Huffnagle, G. B. (2004) · Infection and Immunity · doi:10.1128/iai.72.9.4996-5003.2004 · Cited by 330
Metadata
- Authors
- Demeure, C. E., Yang, L., Desjardins, C., Raynauld, P., & Delespesse, G.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 1997-12
- Volume
- 27
- Issue
- 12
- Pages
- 3526-3531
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2068403491
- Cited by
- 175
- References
- 1
- FWCI
- 6.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prostaglandin E2 primes naive T cells for the production of anti‐inflammatory cytokines. https://app.cochat.ai/papers/10.1002/eji.1830271254
- The paper
- Demeure, C. E., Yang, L., Desjardins, C., Raynauld, P., & Delespesse, G. (1997). Prostaglandin E2 primes naive T cells for the production of anti‐inflammatory cytokines. European Journal of Immunology. https://doi.org/10.1002/eji.1830271254
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.